Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Prometheus Biosciences In...

    NASDAQ: RXDX · Real-Time Price · USD
    199.92
    0.18 (0.09%)
    At close: Jun 15, 2023, 10:00 PM

    Prometheus Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
    Revenue
    		 6.81M 3.13M 1.23M
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 6.81M 3.13M 1.23M
    Operating Income
    		 -145.78M -87.8M -29.01M
    Interest Income
    		 4.03M 108K 13K
    Pretax Income
    		 -141.75M -90.19M -31.14M
    Net Income
    		 -141.75M -89.94M -39.25M
    Selling & General & Admin
    		 39.74M 28.5M 11.09M
    Research & Development
    		 112.85M 62.43M 19.15M
    Other Expenses
    		 n/a n/a -15K
    Operating Expenses
    		 152.59M 90.93M 30.24M
    Interest Expense
    		 n/a 861K 2.13M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 152.59M 90.93M 30.24M
    Income Tax Expense
    		 n/a -258K 8.11M
    Shares Outstanding (Basic)
    		 40.62M 31.33M 34.61M
    Shares Outstanding (Diluted)
    		 40.62M 31.33M 34.61M
    EPS (Basic)
    		 -3.49 -2.87 -1.13
    EPS (Diluted)
    		 -3.49 -2.87 -1.13
    EBITDA
    		 -145.78M -87.8M -28.9M
    EBIT
    		 -145.78M -89.33M -29.01M
    Depreciation & Amortization
    		 629K 258K 107K

    Add to Watchlist